
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PROMETHAZINE HYDROCHLORIDE PLAIN | ANI Pharmaceuticals | N-008381 DISCN | 1982-01-01 | 2 products, RLD |
| PHENERGAN | Delcor Asset | N-007935 DISCN | 1982-01-01 | 3 products, RLD |
| PHENERGAN | Mylan | N-010926 DISCN | 1982-01-01 | 2 products, RLD |
| PHENERGAN | Mylan | N-011689 DISCN | 1982-01-01 | 1 products, RLD |
| PHENERGAN | Wyeth | N-008857 DISCN | 1982-01-01 | 2 products |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PHENERGAN W/ CODEINE | ANI Pharmaceuticals | N-008306 DISCN | 1984-04-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PHENERGAN VC W/ CODEINE | ANI Pharmaceuticals | N-008306 DISCN | 1984-04-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PHENERGAN VC | ANI Pharmaceuticals | N-008604 DISCN | 1984-04-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | ANI Pharmaceuticals | N-011265 RX | 1984-04-02 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MEPERGAN | Hikma Pharmaceuticals | N-011730 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
|---|---|---|
| dextromethorphan hydrobromide and promethazine hydrochloride | ANDA | 2024-06-05 |
| phenadoz | ANDA | 2021-03-01 |
| phenergan | ANDA | 2025-06-30 |
| prometh with codeine | ANDA | 2012-01-24 |
| promethazine | ANDA | 2022-10-08 |
| promethazine and codeine | ANDA | 2009-08-21 |
| promethazine dm | ANDA | 2025-05-31 |
| promethazine hci | ANDA | 2024-02-22 |
| promethazine hcl | ANDA | 2019-11-26 |
| promethazine hcl promethazine hydrochloride | 2006-11-27 |
Code | Description |
|---|---|
| J2180 | Injection, meperidine and promethazine hcl, up to 50 mg |
| J2550 | Injection, promethazine hcl, up to 50 mg |
| Q0169 | Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | 1 | — | 1 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | 1 | — | 1 |
| Syndrome | D013577 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inflammation | D007249 | MP_0001845 | — | — | 1 | — | — | — | 1 |
| Drug common name | Promethazine |
| INN | promethazine |
| Description | Promethazine is a tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety. It has a role as a H1-receptor antagonist, a sedative, an antiemetic, a local anaesthetic, an antipruritic drug, an anti-allergic agent and an anticoronaviral agent. It is a member of phenothiazines and a tertiary amine. It is a conjugate base of a promethazine(1+). |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CC(CN1c2ccccc2Sc2ccccc21)N(C)C |
| PDB | — |
| CAS-ID | 60-87-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL643 |
| ChEBI ID | 8461 |
| PubChem CID | 4927 |
| DrugBank | DB01069 |
| UNII ID | FF28EJQ494 (ChemIDplus, GSRS) |































